Johnson & Johnson (JNJ)
144.47
+0.89
(+0.62%)
USD |
NYSE |
Dec 20, 16:00
144.61
+0.14
(+0.10%)
After-Hours: 20:00
Johnson & Johnson Free Cash Flow: 19.02B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| AbbVie Inc | 15.62B |
| Bristol-Myers Squibb Co | 13.80B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.993B |
| Cash from Investing (Quarterly) | -3.128B |
| Cash from Financing (Quarterly) | -9.882B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 5.42% |